Format

Send to

Choose Destination
See comment in PubMed Commons below
Zh Mikrobiol Epidemiol Immunobiol. 1996 Jan-Feb;(1):75-7.

[The efficacy of the new bacterial preparation biosporin in treating acute intestinal infections].

[Article in Russian]

Author information

1
Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow, Russia.

Abstract

The clinico-laboratory study of the new probiotic Biosporin revealed its effectiveness in the treatment of patients with acute enteric infections. The pronounced curative action of the preparation, manifested by the rapid normalization of stool, the disappearance of abdominal pains and the decrease of dysbiosis in the intestine, was demonstrated. The best results were registered after the administration of Biosporin containing 2 x 10(9) microbial cells (Bacillus subtilis and Bacillus licheniformis). Biosporin was well tolerated by the patients, no side effects were observed. Biosporin is recommended for use in medical practice for the treatment of patients with acute enteric infections.

PMID:
8820685
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center